New silver coated anti-microbial barrier dressing receives Canadian approval
Obese people who don’t have high cholesterol or diabetes might think they’re healthy - despite the extra pounds. But new Ohio University research suggests that obesity raises levels of the hormone leptin, which can be as big a threat to the cardiovascular system as cholesterol. Tadeusz Malinski and colleagues have published the first study to directly
Full Post: Obesity raises levels of hormone leptin
NUCRYST Pharmaceuticals, a developer and manufacturer of medical products that fight infection and inflammation, and the Advanced Wound Management division of Smith & Nephew plc announced today that Health Canada granted marketing approval for Acticoat Flex barrier dressing for wounds that require up to seven days of sustained antimicrobial activity.
Acticoat Flex is a new addition to the Acticoat family of barrier dressings coated with NUCRYST’s patented SILCRYST nanocrystalline silver technology.
“We are pleased that Health Canada has approved Acticoat Flex,” said Thomas E. Gardner, Chairman and Chief Executive Officer of NUCRYST. “This regulatory approval and the proposed launch by Smith & Nephew of Acticoat Flex is the latest result of the successful partnership between NUCRYST and Smith & Nephew to provide advanced antimicrobial protection to acute trauma and burn patients, as well as to patients with chronic wounds.”
The Acticoat brand is a leader in the antimicrobial advanced wound care market. Acticoat Flex simplifies the dressing of wounds with its unique elastic conformable design that easily contours to surfaces, including difficult-to-protect articulating regions such as knee or elbow joints.
“We are very pleased with Acticoat Flex. It represents our commitment in supplying the correct tools for healthcare professionals, to help reduce the risk of Health Care Acquired Infection” commented Joe Woody, President of Smith & Nephew Wound Management. “This product launch is a key to our focus on Infection Management, one of the three focused elements of the Wound Management Global Business Unit strategy along with Exudate Management and Negative Pressure Wound Therapy.”
Antimicrobial barrier dressings are used in the management of infection, a major cause of delays to the wound healing process. Acticoat dressings with NUCRYST’s proprietary SILCRYST nanocrystalline silver coatings deliver rapid antimicrobial activity thereby providing an improved healing environment. Acticoat dressings are now sold by Smith & Nephew in over 30 countries and are used extensively for serious wounds and burns.
A new study suggests that adult bone marrow stem cells can be used in the construction of artificial skin. The findings mark an advancement in wound healing and may be used to pioneer a method of organ reconstruction. The study is published in Artificial Organs , official journal of the International Federation for Artificial Organs
Full Post: Bone marrow stem cells used to regenerate skin
Researchers in one of the external groups of the Instituto Gulbenkian de Ciencia (IGC), in Portugal, have discovered a novel mechanism which regulates the process whereby new blood vessels are formed and wounds heal, including chronic wounds, such as those found in diabetic patients and those suffering from morbid obesity. These findings, by Sergio
Full Post: Discovery of new mechanism that regulates formation of blood vessels
Researchers at the Technion-Israel Institute of Technology have developed a strong, flexible, bio-material that may be used someday to close wounds with minimal scarring and rejection by the immune system. Spun from a common blood protein, the material could be used to make the thin threads needed for wound sutures, larger dressings for wounds, and
Full Post: New nanofibers spun from a common blood protein to close wounds with minimal scarring
Researchers hope to achieve healthy ageing by enhancing body healing capacity and reducing chronic inflammation. Why does wound-healing deteriorate with advanced age? This issue will be addressed thanks to a research grant of nearly ?11 million from the European Commission (EC). Paolo Madeddu, Professor of Experimental Cardiovascluar Medicine at the Bristol Heart Institute, is a
Full Post: Scientists hope European grant can improve healthy ageing
Smith & Nephew’s Endoscopy Division has announced the launch of the CROSSTRAC Hip Guide System, which enables surgeons to accurately establish pathways to diagnose and repair the hip joint using arthroscopy, or minimally invasive, repair procedures. The announcement came at the Arthroscopy Association of North America Fall Course, which opened today and runs through Saturday in
Full Post: New system helps the repair of hip joint using arthroscopy